Shareholder Alert: Ademi & O’Reilly, LLP Investigates Whether NCI, Inc. Has Obtained a Fair Price in Its Sale to OceanFirst...
03 7월 2017 - 11:43PM
Business Wire
Ademi & O’Reilly, LLP is investigating the Board of
Directors of NCI, Inc. (Nasdaq: NCIT) for possible breaches of
fiduciary duty and other violations of Delaware law in connection
with the sale of NCI to H.I.G. Capital, LLC.
Click here to learn how to join the action:
http://ademilaw.com/case/nci-inc or call Guri Ademi toll-free at
866-264-3995. There is no cost or obligation to you.
Ademi & O’Reilly, LLP alleges NCI’s long-term financial
outlook is improving and yet NCI shareholders will receive only
$20.00 per NCI common share. H.I.G. is well aware of NCI’s
improving financial metrics and is purchasing NCI at a substantial
discount. The merger agreement unreasonably limits competing bids
for NCI by (i) prohibiting solicitation of any further bids, and
(ii) imposing a termination penalty should NCI receive and accept a
superior bid. NCI insiders, their affiliates and other major
shareholders own significant voting stock, and will receive
millions of dollars as part of change of control arrangements, and
therefore can unduly influence a sale of NCI. Our investigation
centers on the conduct of NCI’s Board of Directors, who have
unanimously approved the transaction, and whether they are (i)
fulfilling their fiduciary duties to all shareholders, and (ii)
obtaining a fair and reasonable price for NCI given its current
financial condition and prospects.
If you own common stock in NCI and wish to obtain additional
information, please contact Guri Ademi either at
gademi@ademilaw.com or toll-free: 866-264-3995, or
http://ademilaw.com/case/nci-inc.
We specialize in shareholder litigation involving buyouts,
mergers, and individual shareholder rights throughout the country.
For more information, please feel free to call us. Attorney
advertising. Prior results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170703005374/en/
Ademi & O’Reilly, LLPGuri AdemiToll Free: (866) 264-3995Fax:
(414) 482-8001
Nci, Inc. (MM) (NASDAQ:NCIT)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Nci, Inc. (MM) (NASDAQ:NCIT)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
Nci, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Nci, Inc. (MM) News Articles